Sabre Price To Sales Ratio vs Capex To Depreciation Analysis

SABR Stock

USD 3.91 0.14 3.71%

Sabre Corpo financial indicator trend analysis is much more than just breaking down Sabre Corpo prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sabre Corpo is a good investment. Please check the relationship between Sabre Corpo Price To Sales Ratio and its Capex To Depreciation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabre Corpo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide.

Price To Sales Ratio vs Capex To Depreciation

Price To Sales Ratio vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sabre Corpo Price To Sales Ratio account and Capex To Depreciation. At this time, the significance of the direction appears to have no relationship.

The correlation between Sabre Corpo's Price To Sales Ratio and Capex To Depreciation is 0.03. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Sabre Corpo, assuming nothing else is changed. The correlation between historical values of Sabre Corpo's Price To Sales Ratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Sabre Corpo are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Price To Sales Ratio i.e., Sabre Corpo's Price To Sales Ratio and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.03

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Sabre Corpo stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Sabre Corpo sales, a figure that is much harder to manipulate than other Sabre Corpo multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Sabre Corpo's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sabre Corpo current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabre Corpo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide.At this time, Sabre Corpo's Tax Provision is relatively stable compared to the past year. As of 11/29/2024, Enterprise Value Over EBITDA is likely to grow to 55.20, though Discontinued Operations is likely to grow to (580.5 K).

	2021	2022	2023	2024 (projected)
Interest Expense	257.8M	295.2M	447.9M	247.5M
Depreciation And Amortization	262.2M	184.6M	148.7M	160.0M

Interest Expense Depreciation And Amortization

Sabre Corpo fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Common Stock Shares Outstanding		0.18	0.68	-0.04	-0.64	-0.39	-0.18	-0.82	0.48	-0.6	0.35	0.63	-0.33	0.31	0.64	-0.52	0.51	0.91	0.72	-0.36	0.54	0.88	0.68	0.73	0.61	-0.15
Total Assets	0.18		0.03	0.0	-0.29	0.46	0.42	-0.51	-0.33	0.28	0.04	0.41	0.48	0.39	0.39	-0.08	0.73	0.14	0.06	-0.44	0.38	0.2	0.02	-0.08	0.43	0.3
Short Long Term Debt Total	0.68	0.03		-0.47	-0.75	-0.67	-0.72	-0.53	0.83	-0.82	0.24	0.8	-0.58	-0.06	0.81	-0.74	0.51	0.74	0.99	-0.3	0.54	0.77	0.98	0.78	0.76	-0.42
Other Current Liab	-0.04	0.0	-0.47		0.58	0.44	0.66	-0.1	-0.29	0.47	0.48	-0.48	0.47	0.16	-0.47	0.78	0.01	-0.09	-0.52	-0.15	-0.04	-0.21	-0.48	-0.17	-0.4	0.16
Total Current Liabilities	-0.64	-0.29	-0.75	0.58		0.4	0.43	0.69	-0.38	0.62	0.15	-0.85	0.51	-0.28	-0.85	0.78	-0.44	-0.74	-0.82	0.04	-0.52	-0.83	-0.69	-0.59	-0.87	0.46
Total Stockholder Equity	-0.39	0.46	-0.67	0.44	0.4		0.76	0.03	-0.83	0.95	-0.2	-0.24	0.92	0.44	-0.26	0.54	-0.06	-0.43	-0.67	-0.04	-0.09	-0.4	-0.76	-0.79	-0.22	0.58
Property Plant And Equipment Net	-0.18	0.42	-0.72	0.66	0.43	0.76		-0.08	-0.77	0.73	0.03	-0.39	0.74	0.47	-0.4	0.6	0.04	-0.22	-0.67	-0.11	-0.23	-0.27	-0.7	-0.54	-0.36	0.44
Current Deferred Revenue	-0.82	-0.51	-0.53	-0.1	0.69	0.03	-0.08		-0.23	0.3	-0.34	-0.66	0.04	-0.48	-0.66	0.36	-0.7	-0.84	-0.57	0.34	-0.64	-0.87	-0.47	-0.55	-0.7	0.11
Net Debt	0.48	-0.33	0.83	-0.29	-0.38	-0.83	-0.77	-0.23		-0.83	0.49	0.32	-0.64	-0.47	0.34	-0.48	0.3	0.47	0.77	-0.11	0.22	0.48	0.85	0.82	0.28	-0.42
Retained Earnings	-0.6	0.28	-0.82	0.47	0.62	0.95	0.73	0.3	-0.83		-0.2	-0.48	0.9	0.25	-0.5	0.69	-0.23	-0.66	-0.83	0.06	-0.29	-0.64	-0.88	-0.88	-0.46	0.57
Accounts Payable	0.35	0.04	0.24	0.48	0.15	-0.2	0.03	-0.34	0.49	-0.2		-0.11	0.01	-0.36	-0.09	0.27	0.55	0.29	0.15	-0.22	0.09	0.2	0.27	0.38	-0.07	-0.03
Cash	0.63	0.41	0.8	-0.48	-0.85	-0.24	-0.39	-0.66	0.32	-0.48	-0.11		-0.3	0.4	1.0	-0.73	0.53	0.74	0.84	-0.39	0.67	0.78	0.73	0.44	0.97	-0.25
Non Current Assets Total	-0.33	0.48	-0.58	0.47	0.51	0.92	0.74	0.04	-0.64	0.9	0.01	-0.3		0.33	-0.31	0.52	0.08	-0.43	-0.61	-0.2	-0.15	-0.4	-0.64	-0.68	-0.33	0.74
Non Currrent Assets Other	0.31	0.39	-0.06	0.16	-0.28	0.44	0.47	-0.48	-0.47	0.25	-0.36	0.4	0.33		0.39	-0.15	0.12	0.4	0.03	-0.34	0.38	0.41	-0.12	-0.1	0.36	0.22
Cash And Short Term Investments	0.64	0.39	0.81	-0.47	-0.85	-0.26	-0.4	-0.66	0.34	-0.5	-0.09	1.0	-0.31	0.39		-0.73	0.53	0.76	0.85	-0.38	0.67	0.79	0.75	0.46	0.97	-0.26
Net Receivables	-0.52	-0.08	-0.74	0.78	0.78	0.54	0.6	0.36	-0.48	0.69	0.27	-0.73	0.52	-0.15	-0.73		-0.2	-0.58	-0.81	0.08	-0.41	-0.68	-0.75	-0.55	-0.64	0.15
Good Will	0.51	0.73	0.51	0.01	-0.44	-0.06	0.04	-0.7	0.3	-0.23	0.55	0.53	0.08	0.12	0.53	-0.2		0.49	0.49	-0.58	0.52	0.52	0.5	0.44	0.54	-0.02
Common Stock Total Equity	0.91	0.14	0.74	-0.09	-0.74	-0.43	-0.22	-0.84	0.47	-0.66	0.29	0.74	-0.43	0.4	0.76	-0.58	0.49		0.79	-0.32	0.56	0.96	0.73	0.71	0.73	-0.3
Non Current Liabilities Total	0.72	0.06	0.99	-0.52	-0.82	-0.67	-0.67	-0.57	0.77	-0.83	0.15	0.84	-0.61	0.03	0.85	-0.81	0.49	0.79		-0.27	0.52	0.83	0.97	0.78	0.79	-0.42
Inventory	-0.36	-0.44	-0.3	-0.15	0.04	-0.04	-0.11	0.34	-0.11	0.06	-0.22	-0.39	-0.2	-0.34	-0.38	0.08	-0.58	-0.32	-0.27		-0.55	-0.25	-0.33	-0.24	-0.3	-0.33
Other Current Assets	0.54	0.38	0.54	-0.04	-0.52	-0.09	-0.23	-0.64	0.22	-0.29	0.09	0.67	-0.15	0.38	0.67	-0.41	0.52	0.56	0.52	-0.55		0.61	0.46	0.48	0.7	-0.09
Other Stockholder Equity	0.88	0.2	0.77	-0.21	-0.83	-0.4	-0.27	-0.87	0.48	-0.64	0.2	0.78	-0.4	0.41	0.79	-0.68	0.52	0.96	0.83	-0.25	0.61		0.74	0.72	0.77	-0.29
Total Liab	0.68	0.02	0.98	-0.48	-0.69	-0.76	-0.7	-0.47	0.85	-0.88	0.27	0.73	-0.64	-0.12	0.75	-0.75	0.5	0.73	0.97	-0.33	0.46	0.74		0.82	0.68	-0.4
Property Plant And Equipment Gross	0.73	-0.08	0.78	-0.17	-0.59	-0.79	-0.54	-0.55	0.82	-0.88	0.38	0.44	-0.68	-0.1	0.46	-0.55	0.44	0.71	0.78	-0.24	0.48	0.72	0.82		0.44	-0.46
Total Current Assets	0.61	0.43	0.76	-0.4	-0.87	-0.22	-0.36	-0.7	0.28	-0.46	-0.07	0.97	-0.33	0.36	0.97	-0.64	0.54	0.73	0.79	-0.3	0.7	0.77	0.68	0.44		-0.37
Short Term Debt	-0.15	0.3	-0.42	0.16	0.46	0.58	0.44	0.11	-0.42	0.57	-0.03	-0.25	0.74	0.22	-0.26	0.15	-0.02	-0.3	-0.42	-0.33	-0.09	-0.29	-0.4	-0.46	-0.37

Click cells to compare fundamentals

Sabre Corpo Account Relationship Matchups

Sabre Corpo fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	276.2M	289.9M	320.9M	326.7M	346.6M	297.8M
Total Assets	5.7B	6.1B	5.3B	5.0B	4.7B	5.8B
Short Long Term Debt Total	3.3B	4.7B	4.8B	4.7B	4.9B	4.2B
Other Current Liab	672.1M	342.4M	462.1M	537.4M	570.7M	442.3M
Total Current Liabilities	1.0B	621.9M	716.5M	815.6M	914.7M	778.7M
Total Stockholder Equity	939.1M	355.6M	(508.9M)	(884.3M)	(1.4B)	(1.3B)
Property Plant And Equipment Net	641.7M	363.5M	249.8M	229.4M	303.6M	408.9M
Current Deferred Revenue	84.7M	99.5M	81.1M	66.5M	108.3M	154.5M
Net Debt	2.9B	3.2B	3.8B	3.9B	4.2B	3.6B
Retained Earnings	(763.5M)	(2.1B)	(3.0B)	(3.5B)	(4.0B)	(3.8B)
Accounts Payable	187.2M	115.2M	122.9M	171.1M	231.8M	168.0M
Cash	436.2M	1.5B	978.4M	794.9M	648.2M	555.3M
Non Current Assets Total	4.6B	4.2B	3.9B	3.6B	3.5B	3.4B
Non Currrent Assets Other	670.1M	629.8M	678.6M	358.3M	247.3M	235.0M
Cash And Short Term Investments	436.2M	1.5B	978.4M	794.9M	700.2M	559.7M
Net Receivables	546.5M	255.5M	259.9M	353.6M	373.4M	333.6M
Good Will	2.6B	2.6B	2.5B	2.5B	2.6B	2.7B
Common Stock Total Equity	2.9M	3.4M	3.5M	3.5M	4.1M	3.1M
Liabilities And Stockholders Equity	5.7B	6.1B	5.3B	5.0B	4.7B	5.8B
Non Current Liabilities Total	3.7B	5.1B	5.1B	5.0B	5.1B	4.6B
Inventory	69.7M	(3.7M)	42.4M	21.0M	63.9M	53.2M
Other Current Assets	139.2M	133.0M	164.0M	153.8M	85.0M	101.6M
Other Stockholder Equity	1.8B	2.5B	2.6B	2.7B	2.7B	2.1B
Total Liab	4.7B	5.7B	5.8B	5.8B	6.0B	5.7B
Property Plant And Equipment Gross	705.9M	488.6M	2.3B	2.3B	2.2B	2.3B
Total Current Assets	1.1B	1.9B	1.4B	1.4B	1.2B	1.2B
Accumulated Other Comprehensive Income	(149.3M)	(136.0M)	(80.3M)	(65.7M)	(73.9M)	(77.6M)
Short Term Debt	81.6M	64.8M	50.4M	40.6M	20.2M	19.2M
Intangible Assets	573.7M	511.4M	440.7M	410.3M	376.1M	513.9M
Common Stock	2.9M	3.4M	3.5M	3.5M	4.1M	3.2M
Other Liab	397.0M	453.4M	350.9M	235.0M	211.5M	380.4M
Other Assets	627.7M	653.9M	705.7M	312.0M	280.8M	479.1M
Long Term Debt	3.3B	4.6B	4.7B	4.7B	4.8B	4.2B
Property Plant Equipment	641.7M	363.5M	249.8M	314.7M	283.2M	447.2M
Net Tangible Assets	(2.3B)	(2.8B)	(3.4B)	(3.4B)	(3.1B)	(3.2B)
Noncontrolling Interest In Consolidated Entity	8.6M	7.0M	9.2M	11.5M	13.2M	13.9M
Retained Earnings Total Equity	(763.5M)	(2.1B)	(3.0B)	(3.5B)	(3.2B)	(3.0B)

Additional Tools for Sabre Stock Analysis

When running Sabre Corpo's price analysis, check to measure Sabre Corpo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabre Corpo is operating at the current time. Most of Sabre Corpo's value examination focuses on studying past and present price action to predict the probability of Sabre Corpo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabre Corpo's price. Additionally, you may evaluate how the addition of Sabre Corpo to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sabre Price To Sales Ratio vs Capex To Depreciation Analysis

Price To Sales Ratio vs Capex To Depreciation

Price To Sales Ratio vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Capex To Depreciation

Sabre Corpo fundamental ratios Correlations

Sabre Corpo Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sabre Corpo fundamental ratios Accounts

Additional Tools for Sabre Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.98	Short Long Term Debt Total
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments
Total Liab	+ 0.97	Non Current Liabilities Total

Property Plant And Equipment Gross	- 0.88	Retained Earnings
Total Liab	- 0.88	Retained Earnings
Other Stockholder Equity	- 0.87	Current Deferred Revenue
Total Current Assets	- 0.87	Total Current Liabilities
Cash And Short Term Investments	- 0.85	Total Current Liabilities
Cash	- 0.85	Total Current Liabilities